Oncology Practice Group Leaves Allegheny For Former Rival UPCI; Will NSABP Follow?
Cornell, MSKCC, Rockefeller To collaborate In $160M Basic Biological Research Program.
North General, MSK, Form Cancer Prevention Center.
Human Genome Consortium Completes “Working Draft”.
NCI Plans $40M In Grants For Cancer Outcomes Studies.
Reimbursement Of Some Anticancer Drugs Expected To Drop Sharply Under HHS Policy.
FDA Approves Large-Volume Processor For Cytyc’s ThinPrep Pap Test Samples.
Sustained-Release Leuprolide Under Study In Phase III Trial.
Celgene Signs CRADA With NCI For Development Of CDC-501.
Trending Stories
- “Backwater to Blockbuster” chronicles the previously untold story of the explosive growth of St. Jude Children’s Research Hospital
In a conversation with Deborah Doroshow, co-authors Chuck Sherr and Bill Evans discuss their collaborative writing process - DOJ alleges that Yale and UCLA discriminated based on race in medical school admissions
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- How City of Hope is turning microbiome science into better cancer care
- FDA clears fruit-flavored vapes, relaxes enforcement on black-market products with pending premarket applications
Critics say policies clear the way for major tobacco companies to enter fruit-flavored vape market
